Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dapawin-M 10/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

Walron Healthcare Pvt Ltd

Salt Composition

Dapagliflozin (10mg) + Metformin (1000mg)

Overview Dapawin-M 10/1000 Tablet ER

Dapawin-M 10/1000 Extended-Release tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, lessening the likelihood of severe diabetic complications and contributing to heart health protection. Dapawin-M 10/1000 ER can be administered with meals; consistent daily timing aids adherence. Dosage is determined by your physician, and discontinuation requires their consultation to prevent blood sugar spikes and potential risks such as kidney impairment or vision loss. This medication is part of a comprehensive diabetes management plan, incorporating a doctor-recommended diet, physical activity, and weight management. Commonly reported side effects include headache, nausea, vomiting, diarrhea, sore throat, nasal congestion, and rhinorrhea. Adequate hydration minimizes dehydration risk. Genital fungal infections are a possibility; diligent hygiene is recommended for prevention. Prior to commencing treatment, disclose any kidney or liver disease, urinary tract infections, diuretic use, or pregnancy/breastfeeding status to your doctor. Limit alcohol consumption as it may intensify certain side effects. Regular blood glucose monitoring is essential during treatment.

Uses of Dapawin-M 10/1000 Tablet ER

Managing type 2 diabetes

Major Benefits of Dapawin-M 10/1000 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Dapawin-M 10/1000 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Dapawin-M 10/1000 Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Dapawin-M 10/1000 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapawin-M 10/1000 Tablet ER whole; do not damage or alter its form. Administer this extended-release tablet with a meal.

How Dapawin-M 10/1000 Tablet ER works:

Dapagliflozin and Metformin, combined as Dapawin-M 10/1000 Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action optimizes blood sugar control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dapawin-M 10/1000 Tablet ER and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Dapawin-M 10/1000 tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Dapawin-M 10/1000 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Dapawin-M 10/1000 Tablet ER to individuals with impaired renal function. Dosage modification of Dapawin-M 10/1000 Tablet ER might be necessary. Physician consultation is advised.

LiverLiverCAUTION

The extended-release Dapawin-M 10/1000 tablet requires careful administration for individuals with hepatic impairment. Dosage modification might be necessary. Physician consultation is advised.

What if you forget to take Dapawin-M 10/1000 Tablet ER :

Should you forget a Dapawin-M 10/1000 Tablet ER dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dapawin-M 10/1000 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Dapawin-M 10/1000 Tablet ...
117
MRP 135
13% off